Degeneration mydriasis and hyperemia of the iris after superior cervical ganglionectomy in the rabbit. Evidence for release of more than norepinephrine during degeneration of adrenergic terminals.
D000065:Accommodation, Ocular / Q000187:drug effects; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001949:Bretylium Compounds / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004106:Dilatation; D005260:Female; D005725:Ganglia, Autonomic / Q000502:physiology*; D006940:Hyperemia / Q000503:physiopathology*; D007429:Intraocular Pressure; D007498:Iris / Q000098:blood supply* / Q000294:innervation*; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D009410:Nerve Degeneration; D009489:Neurosecretion; D009638:Norepinephrine / Q000378:metabolism*; D010830:Physostigmine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D012039:Regional Blood Flow / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D013562:Sympathectomy; D013564:Sympathetic Nervous System / Q000378:metabolism* / Q000503:physiopathology; D014149:Tranquilizing Agents / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D001949:Bretylium Compounds; D014149:Tranquilizing Agents; D001285:Atropine; D012110:Reserpine; D008012:Lidocaine; D010830:Physostigmine; D011433:Propranolol; D002746:Chlorpromazine; D009638:Norepinephrine